Rawat Mohit 4
4 · Fusion Pharmaceuticals Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Rawat Mohit
President and CBO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+77,900→ 77,900 totalExercise: $7.70Exp: 2032-02-01→ Common Stock (77,900 underlying)
Footnotes (1)
- [F1]This option vests in 48 equal monthly installments beginning on March 1, 2022.